A Phase 4 interventional study of Intertransverse Process Block with 1.5% Lidocaine and Erector Spinae Plane Block with 1.5% Lidocaine in Acute Pain, Postoperative and Regional Anesthesia Block, sponsored by Duke University. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by Duke University · Phase 4, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 19 studies in Pain, Postoperative by Duke University — 6 open to participants now, 6 under way, none of them phase 3. Pain, Postoperative · Duke University.
Among the 19 studies in Pain, Postoperative by Duke University, this one is the 15th largest by enrollment of the 17 interventional ones that give a count, is one of 2 that started in 2025, is one of 11 in phase 4, and was the 14th registered.
5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.
Browse Pain, Postoperative studies →6 of the 19 studies in Pain, Postoperative by Duke University are open now, in 1 country. Recruiting first, the newest first:
Duke University · Sites in United States
Ages 18+ · Healthy volunteers
Duke University · Sites in United States
Ages 18–75
Duke University · Sites in United States
Ages 3–17 · Healthy volunteers
Duke University
Ages 18+ · Healthy volunteers
Duke University
Ages 18–80
By country, each count listing its studies:
Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
19 studies; the count open now beside each. This study's row is marked.
First in 2012; this study’s year is marked. 2 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 13 is below the median of 75 across 4,859 interventional studies indexed under Pain, Postoperative.
Median enrollment 53 across the 17 interventional studies, 36 across the 2 observational. Of the 11 that completed or were terminated, 8 (73%) have results posted.
This tab as a report to print or save as PDF → With an account.
Duke University is the lead sponsor of 2,064 studies on the registry; 271 are open to participants now.
Of its 204 completed or terminated interventional studies of FDA-regulated products, 170 (83%) have results posted.
2 of the studies in Pain, Postoperative by Duke University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07068243Duke UniversityREctus Sheath Trial | 2027-02 |
| NCT07566312Duke UniversityStudy of QL Analgesic Response and Extent | 2027-04 |
Add all 2 to your calendar (.ics) → With an account.
Among the 19 studies in Pain, Postoperative by Duke University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Regional anesthesia techniques (or nerve blocks) are used to provide sensory blockade over the chest wall. The most established technique is thoracic epidural. This provides bilateral spread but is also associated with neuraxial complications, which has led to a decrease in clinical usage. Alternative peripheral nerve block techniques, such as intercostal nerve blocks, eliminate the neuraxial complications but, in turn, require numerous injections to provide unilateral coverage. The introduction of ultrasound-guided (USG) nerve blocks has generated clinical interest in the development of novel paraspinal (non-epidural) nerve block techniques, which will provide multiple dermatomal coverage with a single injection. Two such techniques are the Erector Spinae Plane (ESP) block and the Intertransverse Process (ITP) block. The Intertransverse Process (ITP) block targets a slightly deeper plane than the Erector Spinae Plane (ESP) block and was specifically designed to address the ESP block's variable anesthetic spread. Despite its potential for more localized and precise dermatomal coverage, no prior studies have directly compared the two techniques in terms of their cutaneous distribution.
To compare the dermatomal sensory block distribution, the investigators will use detailed mapping with pinprick, cold, and heat stimuli. The investigators expect similar systemic absorption, the chances of local anesthetic systemic toxicity (LAST) should be equally low, and both blocks should be similarly safe. A total of 14-18 healthy adult volunteers will be included. There will be two different procedure days, separated by at least one week. On each day, the subjects will receive a paraspinal block. Each volunteer will undergo pre-procedure screening on the first visit. The blocks will be performed on the same side, at the same level, by the same anesthesiologist, at least one week apart. An ultrasound-guided ESP block will be administered in one day, and an ITP block on the other. Sensory testing will be performed at baseline and 60-90 minutes after the block injections. Serial samples of blood will be drawn to analyze lidocaine PK (between 0 and 240 minutes post-block).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants receive ESP Block under ultrasound guidance, with 20mL of 1.5% Lidocaine on one visit.
Procedure: Erector Spinae Plane Block with 1.5% Lidocaine · Drug: 1.5% Lidocaine
Participants receive ITP Block under ultrasound guidance, with 20mL of 1.5% Lidocaine on the other visit.
Procedure: Intertransverse Process Block with 1.5% Lidocaine · Drug: 1.5% Lidocaine
For the ITP block, the needle will be advanced further into the intertransverse tissue complex between the T4 and T5 transverse processes, and local anesthetic will be injected just above the superior costotransverse ligament, under ultrasound guidance.
The ESP block will be performed by advancing the needle to the transverse process, under ultrasound guidance, with local anesthetic injected between the erector spinae muscle and the transverse process, targeting a caudad-cephalad spread.
local anesthetic to be used in either the ITP and ESP block
Temperature Discrimination
Skin temperature assessment using gloved ice on the chest wall, to discriminate blocked vs unblocked. Reported as the blocked area in cm\^2.
Time frame: 60 to 90 minutes post each intervention (interventions occurred 7 days apart)
Mechanical Discrimination
Mechanical assessment using a neuropin (pinprick) on the chest wall, to discriminate blocked vs unblocked. Reported as the blocked area in cm\^2.
Time frame: 60 to 90 minutes post each intervention (interventions occurred 7 days apart)
Thermography
Infrared camera will assess skin temperature of the chest wall.
Time frame: 60 to 90 minutes post each intervention (interventions occurred 7 days apart)
Nociceptive Discrimination
Nociceptive stimuli will be delivered using controlled heat to discriminate blocked versus unblocked areas on the chest wall.
Time frame: 60 to 90 minutes post each intervention (interventions occurred 7 days apart)
Number of Participants With Adverse Events
Time frame: 2 days post each block, up to 9 days
13 subjects were recruited to receive both blocks.
| Milestone | Erector Spinae Plane Block, Then Intertransverse Process Block | Intertransverse Process Block, Then Erector Spinae Plane Block |
|---|---|---|
| Started | 7 | 6 |
| Completed | 7 | 6 |
| Not completed | 0 | 0 |
| Milestone | Erector Spinae Plane Block, Then Intertransverse Process Block | Intertransverse Process Block, Then Erector Spinae Plane Block |
|---|---|---|
| Started | 7 | 6 |
| Completed | 7 | 6 |
| Not completed | 0 | 0 |
Skin temperature assessment using gloved ice on the chest wall, to discriminate blocked vs unblocked. Reported as the blocked area in cm\^2.
| cm^2 | Erector Spinae Plane (ESP) Block | Intertransverse Process Block (ITP) Block |
|---|---|---|
| temperature anterior | 0 (0 to 4.7) | 2.96 (0 to 8.29) |
| temperature posterior | 28.3 (14.21 to 82.28) | 41.56 (34 to 52.9) |
| temperature lateral | 10.24 (2.32 to 13.64) | 18.16 (8.25 to 30.88) |
Mechanical assessment using a neuropin (pinprick) on the chest wall, to discriminate blocked vs unblocked. Reported as the blocked area in cm\^2.
| cm^2 | Erector Spinae Plane (ESP) Block | Intertransverse Process Block (ITP) Block |
|---|---|---|
| mechanical anterior | 0 (0 to 7.46) | 2.65 (0 to 9.54) |
| mechanical posterior | 20.35 (7.9 to 24.89) | 32.14 (21.88 to 42.69) |
| mechanical lateral | 2.83 (1.29 to 17.76) | 17.83 (9.03 to 28.34) |
Infrared camera will assess skin temperature of the chest wall.
| degrees Celsius | Erector Spinae Plane (ESP) Block | Intertransverse Process Block (ITP) Block |
|---|---|---|
| Anterior temperature | 33.5 (32.5 to 34.2) | 33.4 (33 to 34.1) |
| Posterior temperature | 33.9 (33.1 to 34.2) | 34.05 (33.55 to 34.32) |
| Lateral temperature | 34.6 (33.5 to 35.2) | 34.35 (34.2 to 34.97) |
Nociceptive stimuli will be delivered using controlled heat to discriminate blocked versus unblocked areas on the chest wall.
| degrees Celsius | Erector Spinae Plane (ESP) Block | Intertransverse Process Block (ITP) Block |
|---|---|---|
| Temperature anterior | 45.73 ± 2.64 | 47.95 ± 1.51 |
| Temperature posterior | 47.89 ± 1.79 | 49.17 ± 1.47 |
| Temperature lateral | 46.05 ± 2.31 | 47.36 ± 1.89 |
| Participants | Erector Spinae Plane (ESP) Block | Intertransverse Process Block (ITP) Block |
|---|---|---|
| Number of Participants With Adverse Events | 0 | 0 |
Collected over 2 days post each block, up to 9 days. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Erector Spinae Plane Block | 0/13 (0%) | 0/13 (0%) | 0/13 (0%) |
| Intertransverse Process Block | 0/13 (0%) | 0/13 (0%) | 0/13 (0%) |
| Age, Continuous(years) | All Study Participants |
|---|---|
| Mean | 31.77 ± 9.51 |
| Sex: Female, Male(Participants) | All Study Participants |
|---|---|
| Female | 3 |
| Male | 10 |
| Race and Ethnicity Not Collected(Participants) | All Study Participants |
|---|
| Height(cm) | All Study Participants |
|---|---|
| Mean | 175.12 ± 12.34 |
| Weight(kg) | All Study Participants |
|---|---|
| Mean | 83.77 ± 27.04 |
| BMI(kg/m^2) | All Study Participants |
|---|---|
| Mean | 27.04 ± 3.14 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from Jun 2025 to primary completion in Jul 2025, 1 month.
Results were first posted in Nov 2026, 1 year 3 months after primary completion.
Of 535 non-industry phase 4 interventional studies under Pain, Postoperative, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 32. This study's 1 month is below that.
Counting every sponsor, half of 545 studies reached it within 16 months; a quarter within 8 and three quarters within 32.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.